Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor

Human Pathology

Volumn 40, Issue 3, 2009, Pages 349-355

  Kohashi, Kenichi ^a   Izumi, Teiyu ^a   Oda, Yoshinao ^a   Yamamoto, Hidetaka ^a   Tamiya, Sadafumi ^a   Taguchi, Tomoaki ^a   Iwamoto, Yukihide ^a   Hasegawa, Tadashi ^b   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epithelioid sarcoma; Immunohistochemistry; Malignant rhabdoid tumor; SMARCB1 INI1

Indexed keywords

DNA; GENE PRODUCT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; EPITHELIOID SARCOMA; FEMALE; GENE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INI1 GENE; MAJOR CLINICAL STUDY; MALE; MUTATION; NUCLEOTIDE SEQUENCE; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHABDOID TUMOR; SMARCB1 GENE;

CHROMOSOMAL PROTEINS, NON-HISTONE; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIERS ESTIMATE; MALE; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 59049105526     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2008.08.007     Document Type: Article

References (23)

1. Biegel J.A., Tan L., Zhang F., et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8 (2002) 3461-3467
2. Imbalzano A.N., and Jones S.N. Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability. Cancer Cell 7 (2005) 294-295
3. Izumi T., Oda Y., Hasegawa T., et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol 19 (2006) 820-831
4. Kingston R.E., Bunker C.A., and Imbalzano A.N. Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 10 (1996) 905-920
5. Schofield D. Extrarenal rhabdoid tumour. In: Fletcher C.D.M., et al. (Ed). WHO Classification of Tumour, Pathology and Genetics of Tumours of Soft Tissue and Bone (2002), IARC Press, Lyon, France 219-220
6. Uno K., Takita J., Yokomori K., et al. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Genes Chromosomes Cancer 34 (2002) 33-41
7. Vries R.G., Bezrookove V., Zuijderduijn L.M., et al. Cancer-associated mutations in chromatin remodeler hSNF5 promote chromosomal instability by compromising the mitotic checkpoint. Genes Dev 19 (2005) 665-670
8. Biegel J.A., Zhou J.Y., Rorke L.B., et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59 (1999) 74-79
9. Bourdeaut F., Freneaux P., Thuille B., et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol 211 (2007) 323-330
10. Hoot A.C., Russo P., Judkins A.R., et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 28 (2004) 1485-1491
11. Judkins A.R., Mauger J., Ht A., et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28 (2004) 644-650
12. Kohashi K., Oda Y., Yamamoto H., et al. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. J Cancer Res Clin Oncol 133 (2007) 817-824
13. Oda Y., and Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other sort-tissue sarcomas with rhabdoid features. Pathol Int 56 (2006) 287-295
14. Sigauke E., Rakheja D., Maddox D.L., et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol 19 (2006) 717-725
15. Modena P., Lualdi E., Facchinetti F., et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 65 (2005) 4012-4019
16. Saito T., Oda Y., Itakura E., et al. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor. Pathol Int 51 (2001) 532-542
17. Guillou L., and Kaneko Y. Epithelioid sarcoma. In: Fletcher C.D.M., et al. (Ed). WHO Classification of Tumour, Pathology and Genetics of Tumours of Soft Tissue and Bone (2002), IARC Press, Lyon, France 205-207
18. Kohashi K., Oda Y., Yamamoto H., et al. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 32 (2008) 1168-1174
19. Aveyard J.S., and Knowles M.A. Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification. J Mol Diagn 6 (2004) 356-365
20. Berggren P., Kumar R., Sakano S., et al. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clin Cancer Res 9 (2003) 235-242
21. Labuhn M., Jones G., Speel E.J., et al. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas. Oncogene 20 (2001) 1103-1109
22. Guillou L., Wadden C., Coindre J.M., et al. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol 21 (1997) 130-146
23. Miettinen M., Fanburg-Smith J.C., Virolainen M., et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol 30 (1999) 934-942